|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.435 USD | +2.74% |
|
+8.37% | +36.67% |
| May. 13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| May. 13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 191M 165M 154M 142M 268M 18.16B 271M 1.81B 711M 9.08B 717M 701M 30.09B | P/E 2026 * |
12.2x | P/E 2027 * | 47.4x |
|---|---|---|---|---|---|
| Enterprise Value | 191M 165M 154M 142M 268M 18.16B 271M 1.81B 711M 9.08B 717M 701M 30.09B | EV / Sales 2026 * |
2.44x | EV / Sales 2027 * | 2.83x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protalix BioTherapeutics, Inc.
| 1 day | +1.90% | ||
| 1 week | +5.72% | ||
| Current month | +1.26% | ||
| 1 month | +4.34% | ||
| 3 months | +22.44% | ||
| 6 months | -17.53% | ||
| Current year | +33.33% |
| 1 week | 2.2 |  | 2.48 |
| 1 month | 2.2 | | 2.48 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.42 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 2019-06-29 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 2025-08-23 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 2008-06-30 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 2014-10-31 |
Dror Bashan
BRD | Director/Board Member | 59 | 2019-06-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/19/25 | Buy | Chief Executive Officer | 56,000 | 0.0696% | ||
| 11/18/25 | Sell | Director | 168 | 0.0002% | ||
| 9/3/25 | Free | Chief Operating Officer | 75,000 | 0.0941% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.90% | +5.72% | +69.01% | +26.31% | 191M | |
| +3.00% | -3.82% | +51.94% | +156.30% | 995B | |
| +1.10% | -2.81% | +51.15% | +49.09% | 614B | |
| +0.82% | -6.19% | +24.41% | +64.31% | 431B | |
| +1.96% | +0.83% | +42.80% | +37.70% | 353B | |
| -0.11% | -4.07% | +30.37% | +38.52% | 293B | |
| +2.52% | -8.36% | +7.27% | +10.56% | 245B | |
| +4.28% | +5.52% | +36.31% | +61.72% | 210B | |
| -4.32% | -12.94% | -3.79% | -46.07% | 210B | |
| -3.32% | -1.49% | +16.26% | +62.08% | 168B | |
| Average | +0.88% | -4.35% | +32.57% | +46.05% | 351.84B | |
| Weighted average by Cap. | +1.51% | -5.89% | +36.65% | +72.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.3M 67.81M 63.21M 58.14M 110M 7.45B 111M 743M 292M 3.73B 294M 288M 12.34B | 67.56M 58.52M 54.55M 50.17M 94.71M 6.42B 95.77M 641M 252M 3.21B 254M 248M 10.65B |
| Net income | 15.72M 13.62M 12.69M 11.67M 22.04M 1.5B 22.29M 149M 58.55M 748M 59.05M 57.75M 2.48B | 4.07M 3.53M 3.29M 3.02M 5.71M 387M 5.77M 38.65M 15.17M 194M 15.3M 14.96M 642M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-05 | $2.465 | +4.01% | 299,368 |
| 26-08-04 | $2.370 | +2.16% | 716,163 |
| 26-08-03 | $2.320 | -2.11% | 1,027,427 |
| 26-07-31 | $2.370 | +4.41% | 1,232,753 |
| 26-07-30 | $2.270 | 0.00% | 267,199 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
